• Safety Syringes
• About Safety Syringes
  • About Safety Syringes
  • The Company
  • Key Management
  • Corporate Presentation
  • Privacy
  • Terms of Use
  • Mission Statement
  • Quality Commitment
• UltraSafe Products
  • UptraSafe Products
  • UltraSafe Passive Delivery System
  • Tamper Evident UltraSafe Passive® Delivery System
  • UltraSafe Passive Delivery System for Luer Lock and Luer Slip Syringes
  • Safetyject ™ &emdash; Auto Injector with UltraSafe Passive® Delivery System
  • UltraSafe® Needle Guards
  • Market Research
• Pharma Solutions
  • Pharmaceutical Solutions
  • UltraSafe® Delivers Innovation
  • UltraSafe Delivers Automated Assembly
  • UltraSafe Delivers Product Development
  • UltraSafe® Delivers Custom Engineering
  • UltraSafe® Delivers Proprietary Technology
  • UltraSafe Delivers Quality Systems
  • UltraSafe ® Delivers to Pharmaceutical Partners
  • Product Brochure
  • Directions for Use
  • Product Brochure
  • Directions for Use
  • UltraSafe® Delivers Clinical Acceptance
  • The UltraSafe Passive® Delivery System
  • Tamper Evident UltraSafe Passive® Delivery System
  • UltraSafe Passive® Delivery System for Luer Lock and Luer Slip Syringes
  • UltraSafe® Needle Guards
• Legislation
  • Legislation to Combat the Dangers of Accidental Needlesticks
  • Legislation - United States
  • EU Regulatory Response to Sharps Injuries
  • A message from our CEO
  • Spain - Check back for updates
  • Canada - Check back for updates
  • France - Check back for updates
  • Belguim - Check back for updates
  • Australia - Check back for updates
  • Italy - Check back for updates
  • United Kingdom - Check back for updates
• Careers
  • Career Overview
  • Current Job Openings
  • Career Benifits
• Contact Safety Syringes
• News
  • Safety Syringes, Inc. Moves into New Headquarters and Manufacturing Facility
  • FDA Approves Merck's GARDASIL®*, the World's First and Only Cervical Cancer Vaccine
  • News

Privacy Statement  |   Sitemap  |   Terms of Use